Bone Health

Latest News

biosimilar check in banner
Biosimilars Check In: Vegzelma Launch, BLA Acceptances, China Approval

April 26th 2023

Over the past week, Vegzelma, a bevacizumab biosimilar, launched in the United States; 2 biologics license applications (BLAs) for biosimilars were accepted for review by the FDA; and China’s regulatory agency approved a denosumab biosimilar.

doctor filling orange syringe
A Long Time Coming: Dr Sophia Humphreys Details What’s Coming Down the Biosimilar Pipeline

March 23rd 2023

sandoz logo over image of molecule
FDA Accepts Sandoz Denosumab BLA for Review

February 6th 2023

biosimilars check-in graphic
Biosimilars Check-in: Approval in Saudi Arabia, Launch in Republic of Korea, Dr. Reddy’s Completes Study

January 26th 2023

woman shitting and holding her knee, an x-ray image showing pain her bone
Study: Denosumab Biosimilar Looks Promising for Osteoporosis in Phase 3 Trial

January 18th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.